✦ LIBER ✦

Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands

✍ Scribed by Stevanovic, J.; Pompen, M.; Le, H.H.; Rozenbaum, M.H.; Postma, M.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic Evaluation of Warfarin, Dabigat

✍ Wisløff, Torbjørn; Hagen, Gunhild; Klemp, Marianne 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 765 KB

Economic evaluation of apixaban for atri

✍ Rosado-Buzzo, A.; Garcia-Mollinedo, L.; Luna-Casas, G.; Lutz, M.A.; Bogantes, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV47 Economic Evaluation of Dabigatran

✍ H.H. Le; P. Pechlivanoglou; P.M. Engelfriet; M.J. Postma; W.K. Redekop 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

COST-EFFECTIVENESS OF APIXABAN COMPARED

✍ Soyon Lee; Moise Anglade; Kelly Hagstrom; Joy Meng; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Economic evaluation of rivaroxaban in st

✍ Kourlaba, Georgia; Maniadakis, Nikos; Andrikopoulos, George; Vardas, Panos 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 251 KB